vs
NEOGEN CORP（NEOG）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
NEOGEN CORP的季度营收约是Rapid7, Inc.的1.1倍（$224.7M vs $209.7M），Rapid7, Inc.净利率更高（0.5% vs -7.1%，领先7.6%），Rapid7, Inc.同比增速更快（-0.3% vs -2.8%），Rapid7, Inc.自由现金流更多（$125.0M vs $7.8M），过去两年Rapid7, Inc.的营收复合增速更高（0.4% vs -0.9%）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
NEOG vs RPD — 直观对比
营收规模更大
NEOG
是对方的1.1倍
$209.7M
营收增速更快
RPD
高出2.6%
-2.8%
净利率更高
RPD
高出7.6%
-7.1%
自由现金流更多
RPD
多$117.2M
$7.8M
两年增速更快
RPD
近两年复合增速
-0.9%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $209.7M |
| 净利润 | $-15.9M | $1.1M |
| 毛利率 | 47.5% | 69.1% |
| 营业利润率 | -2.4% | 30.6% |
| 净利率 | -7.1% | 0.5% |
| 营收同比 | -2.8% | -0.3% |
| 净利润同比 | 96.5% | -66.7% |
| 每股收益（稀释后） | $-0.07 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGRPD
| Q1 26 | — | $209.7M | ||
| Q4 25 | $224.7M | $217.4M | ||
| Q3 25 | $209.2M | $218.0M | ||
| Q2 25 | $225.4M | $214.2M | ||
| Q1 25 | $221.0M | $210.3M | ||
| Q4 24 | $231.3M | $216.3M | ||
| Q3 24 | $217.0M | $214.7M | ||
| Q2 24 | $236.8M | $208.0M |
净利润NEOGRPD
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-15.9M | $3.1M | ||
| Q3 25 | $36.3M | $9.8M | ||
| Q2 25 | $-612.3M | $8.3M | ||
| Q1 25 | $-10.9M | $2.1M | ||
| Q4 24 | $-456.3M | $2.2M | ||
| Q3 24 | $-12.6M | $15.4M | ||
| Q2 24 | $-5.4M | $6.5M |
毛利率NEOGRPD
| Q1 26 | — | 69.1% | ||
| Q4 25 | 47.5% | 68.9% | ||
| Q3 25 | 45.4% | 70.2% | ||
| Q2 25 | 41.2% | 70.6% | ||
| Q1 25 | 49.9% | 71.7% | ||
| Q4 24 | 49.0% | 69.5% | ||
| Q3 24 | 48.4% | 70.6% | ||
| Q2 24 | 47.9% | 70.7% |
营业利润率NEOGRPD
| Q1 26 | — | 30.6% | ||
| Q4 25 | -2.4% | 1.0% | ||
| Q3 25 | -7.7% | 2.7% | ||
| Q2 25 | -271.1% | 1.6% | ||
| Q1 25 | 2.4% | -0.0% | ||
| Q4 24 | -197.8% | 3.4% | ||
| Q3 24 | 1.0% | 6.0% | ||
| Q2 24 | 5.5% | 2.5% |
净利率NEOGRPD
| Q1 26 | — | 0.5% | ||
| Q4 25 | -7.1% | 1.4% | ||
| Q3 25 | 17.4% | 4.5% | ||
| Q2 25 | -271.6% | 3.9% | ||
| Q1 25 | -4.9% | 1.0% | ||
| Q4 24 | -197.3% | 1.0% | ||
| Q3 24 | -5.8% | 7.2% | ||
| Q2 24 | -2.3% | 3.1% |
每股收益（稀释后）NEOGRPD
| Q1 26 | — | $0.02 | ||
| Q4 25 | $-0.07 | $0.05 | ||
| Q3 25 | $0.17 | $0.15 | ||
| Q2 25 | $-2.82 | $0.13 | ||
| Q1 25 | $-0.05 | $0.03 | ||
| Q4 24 | $-2.10 | $0.08 | ||
| Q3 24 | $-0.06 | $0.21 | ||
| Q2 24 | $-0.02 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | $670.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $174.8M |
| 总资产 | $3.4B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEOGRPD
| Q1 26 | — | $670.3M | ||
| Q4 25 | $145.3M | $474.7M | ||
| Q3 25 | $138.9M | $407.1M | ||
| Q2 25 | $129.0M | $511.7M | ||
| Q1 25 | $127.7M | $493.5M | ||
| Q4 24 | $140.2M | $521.7M | ||
| Q3 24 | $120.5M | $443.7M | ||
| Q2 24 | $170.9M | $442.6M |
股东权益NEOGRPD
| Q1 26 | — | $174.8M | ||
| Q4 25 | $2.1B | $154.7M | ||
| Q3 25 | $2.1B | $127.2M | ||
| Q2 25 | $2.1B | $90.4M | ||
| Q1 25 | $2.7B | $52.7M | ||
| Q4 24 | $2.7B | $17.7M | ||
| Q3 24 | $3.1B | $-5.1M | ||
| Q2 24 | $3.1B | $-52.6M |
总资产NEOGRPD
| Q1 26 | — | $1.7B | ||
| Q4 25 | $3.4B | $1.7B | ||
| Q3 25 | $3.4B | $1.7B | ||
| Q2 25 | $3.4B | $1.6B | ||
| Q1 25 | $4.0B | $1.6B | ||
| Q4 24 | $4.1B | $1.7B | ||
| Q3 24 | $4.5B | $1.6B | ||
| Q2 24 | $4.5B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $39.8M |
| 自由现金流经营现金流 - 资本支出 | $7.8M | $125.0M |
| 自由现金流率自由现金流/营收 | 3.5% | 59.6% |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | — | 35.24× |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $242.8M |
8季度趋势，按日历期对齐
经营现金流NEOGRPD
| Q1 26 | — | $39.8M | ||
| Q4 25 | $19.4M | $37.6M | ||
| Q3 25 | $10.9M | $39.0M | ||
| Q2 25 | $16.4M | $47.5M | ||
| Q1 25 | $19.5M | $29.8M | ||
| Q4 24 | $40.3M | $63.8M | ||
| Q3 24 | $-17.9M | $44.0M | ||
| Q2 24 | $26.7M | $32.9M |
自由现金流NEOGRPD
| Q1 26 | — | $125.0M | ||
| Q4 25 | $7.8M | $36.4M | ||
| Q3 25 | $-13.1M | $34.8M | ||
| Q2 25 | $349.0K | $46.6M | ||
| Q1 25 | $-13.4M | $28.4M | ||
| Q4 24 | $23.1M | $62.6M | ||
| Q3 24 | $-56.3M | $42.6M | ||
| Q2 24 | $2.5M | $32.6M |
自由现金流率NEOGRPD
| Q1 26 | — | 59.6% | ||
| Q4 25 | 3.5% | 16.8% | ||
| Q3 25 | -6.3% | 16.0% | ||
| Q2 25 | 0.2% | 21.8% | ||
| Q1 25 | -6.1% | 13.5% | ||
| Q4 24 | 10.0% | 28.9% | ||
| Q3 24 | -26.0% | 19.9% | ||
| Q2 24 | 1.1% | 15.7% |
资本支出强度NEOGRPD
| Q1 26 | — | — | ||
| Q4 25 | 5.2% | 0.5% | ||
| Q3 25 | 11.5% | 1.9% | ||
| Q2 25 | 7.1% | 0.4% | ||
| Q1 25 | 14.9% | 0.6% | ||
| Q4 24 | 7.4% | 0.5% | ||
| Q3 24 | 17.7% | 0.6% | ||
| Q2 24 | 10.2% | 0.1% |
现金转化率NEOGRPD
| Q1 26 | — | 35.24× | ||
| Q4 25 | — | 12.01× | ||
| Q3 25 | 0.30× | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
RPD
| Product subscriptions | $204.0M | 97% |
| Other | $5.6M | 3% |
